These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21585288)

  • 21. A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers.
    Cassella JV; Spyker DA; Yeung PP
    Int J Clin Pharmacol Ther; 2015 Nov; 53(11):963-71. PubMed ID: 26501204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
    Stier B; Fossler M; Liu F; Caltabiano S
    Clin Ther; 2015 Jul; 37(7):1541-54. PubMed ID: 26138866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac safety of rasagiline, a selective monoamine oxidase type B inhibitor for the treatment of Parkinson's disease: a thorough QT/QTc study.
    Mendzelevski B; Sprenger CR; Spiegelstein O; Rabinovich-Guilatt L
    Int J Clin Pharmacol Ther; 2014 Mar; 52(3):192-201. PubMed ID: 24447649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.
    Louw C; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbroker D; Bardin PG
    Respiration; 2007; 74(4):411-7. PubMed ID: 16954654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of pharmacokinetic interaction between roflumilast and digoxin in healthy adults.
    Eckermann G; Lahu G; Nassr N; Bethke TD
    J Clin Pharmacol; 2012 Feb; 52(2):251-7. PubMed ID: 21257799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonide.
    Hermann R; Siegmund W; Giessmann T; Westphal K; Weinbrenner A; Hauns B; Reutter F; Lahu G; Zech K; Bethke TD
    J Clin Pharmacol; 2007 Aug; 47(8):1005-13. PubMed ID: 17660483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ponesimod, a selective S1P1 receptor modulator, on the QT interval in healthy individuals.
    Hoch M; Darpo B; Brossard P; Zhou M; Stoltz R; Dingemanse J
    Basic Clin Pharmacol Toxicol; 2015 May; 116(5):429-37. PubMed ID: 25287214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma.
    Bousquet J; Aubier M; Sastre J; Izquierdo JL; Adler LM; Hofbauer P; Rost KD; Harnest U; Kroemer B; Albrecht A; Bredenbröker D
    Allergy; 2006 Jan; 61(1):72-8. PubMed ID: 16364159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronopharmacology of roflumilast: a comparative pharmacokinetic study of morning versus evening administration in healthy adults.
    Bethke TD; Huennemeyer A; Lahu G; Lemmer B
    Chronobiol Int; 2010 Oct; 27(9-10):1843-53. PubMed ID: 20969527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of fluvoxamine on the pharmacokinetics of roflumilast and roflumilast N-oxide.
    von Richter O; Lahu G; Huennemeyer A; Herzog R; Zech K; Hermann R
    Clin Pharmacokinet; 2007; 46(7):613-22. PubMed ID: 17596106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.
    Pritchett EL; Schulte MC; Schnell D; Marcello SR; Wilkinson WE; Page RL; Connolly SJ;
    J Clin Pharmacol; 2002 Apr; 42(4):388-94. PubMed ID: 11936563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
    Mondal SA; Assaf M; Liu L; O'Mara E
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):251-8. PubMed ID: 26754679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects.
    Démolis JL; Kubitza D; Tennezé L; Funck-Brentano C
    Clin Pharmacol Ther; 2000 Dec; 68(6):658-66. PubMed ID: 11180026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation.
    Mansbach RS; Ludington E; Rogowski R; Kittrelle JP; Jochelson P
    Clin Ther; 2011 Jul; 33(7):851-62. PubMed ID: 21722958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
    Wang Z; Grasela DM; Krishna G
    Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjects.
    Hauns B; Hermann R; Hünnemeyer A; Herzog R; Hauschke D; Zech K; Bethke TD
    J Clin Pharmacol; 2006 Oct; 46(10):1146-53. PubMed ID: 16988203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of vardenafil and sildenafil on cardiac repolarization.
    Morganroth J; Ilson BE; Shaddinger BC; Dabiri GA; Patel BR; Boyle DA; Sethuraman VS; Montague TH
    Am J Cardiol; 2004 Jun; 93(11):1378-83, A6. PubMed ID: 15165918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of epinephrine over P wave duration and ventricular repolarization in subjects without structural heart disease.
    Fuenmayor AJ; Luisangelli Gómez R; Solórzano MI
    Int J Cardiol; 2016 Feb; 204():142-6. PubMed ID: 26657609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study.
    Shen Z; Gillen M; Tieu K; Nguyen M; Harmon E; Wilson DM; Kerr B; Lee CA
    Drug Des Devel Ther; 2016; 10():3509-3517. PubMed ID: 27826183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.